Welcome to the Master's of Microbial Biotechnology at North Carolina State University!

The MMB program presents a unique blend of science and business, mixed with real-world biotechnology projects and internships, to give you the experiences you need to become the biotechnology professional that you want to be!    

The Professional Science Master’s degree in Microbial Biotechnology (MMB) at North Carolina State University --

  • provides students with interdisciplinary academic training in both science and business
  • prepares students to work broadly in multiple areas and effectively in project teams
  • promotes development of strong communication skills that foster effective dialogue between individuals, companies and communities
  • enhances the ability to apply skills to real problems faced by biotechnology companies
  • develops comfort with big data management
  • urges creativity and innovation
  • prompts the ability to make decisions based upon information available
  • drives a capacity for coping with uncertainty and risk, and adapting to change

The MMB program developed in response to the Biotechnology Industry’s desire for employees with a strong technical aptitude along with an understanding of business issues and well-developed professional skills. The MMB curriculum includes academic coursework in science and business along with professional training provided by local companies through case study projects and internships.

Explore the MMB program's website and contact us if you have any questions.

View our most recent newsletter.

Visit our Recent News and Events page to learn about the latest developments in the program, for opportunities to meet current MMB students and alumni, and to learn more about the program. 

To download a one-page brochure about the program, click here.  For a four-page brochure, click here

MMB Alumni work in a variety of companies such as The Hamner Institutes for Health Sciences, GlaxoSmithKline, and Novozymes.

View this YouTube video that highlights the career paths for three MMB alumni.


Biotechnology in North Carolina, at NCSU, and in the News

North Carolina is ranked 3rd in the nation in number of biotech companies with over 500 companies employing more than 57,000 people. North Carolina's strong science, thriving industry and low cost of doing business offer biotechnology companies an opportunity like nowhere else in the world. The Research Triangle Park (RTP), a 7,000 acre development, is one of the oldest and largest science parks in North America and is home to more than 170 companies. For additional information on North Carolina's Biotechnology sector, please visit the North Carolina Biotechnology Center's website: www.ncbiotech.org.

North Carolina State University is home to over 33,000 students. NC State's Centennial Campus, a research campus located just south of main campus, houses over 130 companies, several university departments, the Biomanufacturing Training and Education Center (BTEC), and the Technology Incubator. For more information on NC State's Centennial Campus visit: centennial.ncsu.edu.

Biotechnology in the news...

High-throughput functional genomics using CRISPR–Cas9

Forward genetic screens are powerful tools for the discovery and functional annotation of genetic elements. Recently, the RNA-guided CRISPR (clustered regularly interspaced short palindromic repeat)-associated Cas9 nuclease has been combined with genome-scale guide RNA libraries for unbiased, phenotypic screening. In this Review, we describe recent advances using Cas9 for genome-scale screens, including knockout approaches that inactivate genomic loci and strategies that modulate transcriptional activity. We discuss practical aspects of screen design, provide comparisons with RNA interference (RNAi) screening, and outline future applications and challenges.

Turning On Genes, Systematically, with CRISPR/Cas9

With the latest CRISPR/Cas9 advance, the exhortation “turn on, tune in, drop out” comes to mind. The CRISPR/Cas9 gene-editing system was already a well-known means of “tuning in” (inserting new genes) and “dropping out” (knocking out genes). But when it came to “turning on” genes, CRISPR/Cas9 had little potency. That is, it had demonstrated only limited success as a way to activate specific genes... read more.

More from Genetic Engineering and Biotechnology news.

Large-scale test of the natural refuge strategy for delaying insect resistance to transgenic Bt crops

More from Nature Biotechnology.